The promise of reverse vaccinology
- PMID: 25733557
- DOI: 10.1093/inthealth/ihv002
The promise of reverse vaccinology
Abstract
Reverse vaccinology (RV) is a computational approach that aims to identify putative vaccine candidates in the protein coding genome (proteome) of pathogens. RV has primarily been applied to bacterial pathogens to identify proteins that can be formulated into subunit vaccines, which consist of one or more protein antigens. An RV approach based on a filtering method has already been used to construct a subunit vaccine against Neisseria meningitidis serogroup B that is now registered in several countries (Bexsero). Recently, machine learning methods have been used to improve the ability of RV approaches to identify vaccine candidates. Further improvements related to the incorporation of epitope-binding annotation and gene expression data are discussed. In the future, it is envisaged that RV approaches will facilitate rapid vaccine design with less reliance on conventional animal testing and clinical trials in order to curb the threat of antibiotic resistance or newly emerged outbreaks of bacterial origin.
Keywords: Bacterial pathogen; Epidemic; Reverse vaccinology; Subunit vaccine.
© The Author 2015. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Reverse vaccinology--in search of a genome-derived meningococcal vaccine.Vaccine. 2006 Apr 12;24 Suppl 2:S2-11-2. doi: 10.1016/j.vaccine.2005.01.103. Vaccine. 2006. PMID: 16823908 Review.
-
Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine.Expert Rev Vaccines. 2010 Oct;9(10):1203-17. doi: 10.1586/erv.10.116. Expert Rev Vaccines. 2010. PMID: 20923270 Review.
-
Enhancing the Biological Relevance of Machine Learning Classifiers for Reverse Vaccinology.Int J Mol Sci. 2017 Feb 1;18(2):312. doi: 10.3390/ijms18020312. Int J Mol Sci. 2017. PMID: 28157153 Free PMC article.
-
Reverse vaccinology and vaccines for serogroup B Neisseria meningitidis.Adv Exp Med Biol. 2005;568:217-23. doi: 10.1007/0-387-25342-4_15. Adv Exp Med Biol. 2005. PMID: 16107075
-
A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease.Expert Rev Vaccines. 2011 May;10(5):575-88. doi: 10.1586/erv.11.32. Expert Rev Vaccines. 2011. PMID: 21604979 Review.
Cited by
-
Positive-unlabeled learning identifies vaccine candidate antigens in the malaria parasite Plasmodium falciparum.NPJ Syst Biol Appl. 2024 Apr 27;10(1):44. doi: 10.1038/s41540-024-00365-1. NPJ Syst Biol Appl. 2024. PMID: 38678051 Free PMC article.
-
An evaluation of different classification algorithms for protein sequence-based reverse vaccinology prediction.PLoS One. 2019 Dec 13;14(12):e0226256. doi: 10.1371/journal.pone.0226256. eCollection 2019. PLoS One. 2019. PMID: 31834914 Free PMC article.
-
Identification of potential candidate vaccines against Mycobacterium ulcerans based on the major facilitator superfamily transporter protein.Front Immunol. 2022 Nov 8;13:1023558. doi: 10.3389/fimmu.2022.1023558. eCollection 2022. Front Immunol. 2022. PMID: 36426350 Free PMC article.
-
Development of a novel multi-epitope vaccine against Ureaplasma urealyticum infection through reverse vaccinology approach.Mol Divers. 2025 Jun 19. doi: 10.1007/s11030-025-11234-2. Online ahead of print. Mol Divers. 2025. PMID: 40537712
-
Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine.Biomed Res Int. 2022 Jul 6;2022:7205241. doi: 10.1155/2022/7205241. eCollection 2022. Biomed Res Int. 2022. PMID: 35845955 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical